Biotech drug maker Amgen plans to launch six biosimilar drugs starting in 2017, according to published reports.
The Food and Drug Administration has approved a new use for a cancer drug made by Roche unit Genentech, the agency said.
The Food and Drug Administration has approved a drug made by Eli Lilly and Bristol-Myers Squibb for treating a form of colorectal cancer, the two companies said.
The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb for treating head and neck cancer, the agency said Monday.
An investigative biotech drug administered together with chemotherapy helped extend the lives of cancer patients...
An investigational biotech drug didn’t significantly improve patients’ survival, according to results of a late-stage...
An investigational drug for skin cancer that had spread to other parts of the body...
Data from a late-stage clinical trial of an investigational drug by Boehringer Ingelheim could show...
The cancer drug arm of Eli Lilly plans to show data from more than 50...